Daniel Orrego
banner
hippocratesresearchfoundation.org
Daniel Orrego
@hippocratesresearchfoundation.org
Studying the intersection of metabolism and disease.
Following is a master class regarding the nuances of Hyperbaric Oxygen Therapy as a critical element in the management of cancer, in context to glucose and ketone control:
youtu.be/Chjp9kDFAe4?...
Can This Starve Cancer? - Surprising Diet & Lifestyle Tips That Fight Disease! | Dominic D'Agostino
LUMEBOX is sponsoring today's show. Right now, Lumebox is offering my community $260 off their portable Red Light device! That's over 50% off! Visit https:/...
youtu.be
April 23, 2024 at 1:53 PM
It is not entirely unusual for folks who have not read Dr. Thomas Seyfried's book, 'Cancer As A Metabolic Disease' to have any number of questions regarding the particulars of metabolic therapies. Following is a useful roundtable discussion in this regard:
youtu.be/pm2ia_Nsfc8?...
Starving Cancer: Breaking Down Thomas Seyfried's Radical & Controversial Protocol
Dr. Thomas Seyfried's groundbreaking research approaches cancer as a metabolic dysfunction and addresses its root cause. Although controversial, this approac...
youtu.be
February 28, 2024 at 9:01 PM
How can we know that Hyperbaric Oxygen Therapy induces cell membrane damage to tumor cells? Because, the effects of oxidative stress from hyperoxia on cell morphology has been demonstrated using atomic force microscopy, in context to metabolic isolation, via lowering of glucose.
February 12, 2024 at 3:57 PM
Why is there an absence of gene mutations and chromosomal abnormalities in some cancers? For example, Greenman et al. found no mutations following extensive sequencing in 73/210 cancers. Cancer cells with no mutations should not exist according to the Somatic Mutation Theory.
Patterns of somatic mutation in human cancer genomes - Nature
518 protein kinase genes in the human genome have been sequenced in a large sample of tumours, providing a global view of the patterns of mutations found and the variations in the number and type of m...
www.nature.com
January 30, 2024 at 1:55 PM
While most efforts to understand cancer immune resistance largely focus on somatic alterations of cancer cells, comparatively less information is available about environmental factors affecting the delicate balance between metabolism, microbiota, immunity, and oncogenesis.
January 26, 2024 at 12:30 PM
Glioma cells are incapable of compensating for glucose restriction by metabolizing ketone bodies in vitro, suggesting a potential disadvantage of tumor cells compared to normal cells under a calorie and macronutrient controlled nutritional regimen.
January 24, 2024 at 12:35 PM
Diagnostic imaging in the form of ultra high resolution Time of Flight PET/CT scanning, constitutes the gold standard for assessing tumor location and dimension, along with the metabolic intensity of a given lesion, as quantified via Standard Uptake Values.

ascopubs.org/doi/10.1200/...
Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Con...
PURPOSE Patients with locally advanced breast cancer (LABC) typically undergo staging tests at presentation. If staging does not detect metastases, treatment consists of curative intent combined modal...
ascopubs.org
January 17, 2024 at 4:00 PM
Direct calorimetry as applied to the measurement of the heat production rate in tumour cells, demonstrates that tumor metabolism is accompanied
by either production or adsorption of heat, whereby the measurement of heat production provides a means for monitoring overall survivorship.
January 15, 2024 at 12:44 PM
Given that tumor microenvironments are lacking in key nutrients and oxygen, cancer becomes resistant to chemo and radiation. Conventional anticancer drugs, such as 5-FU
and cisplatin, exert cytotoxic effects in
normal medium but only have a minimal effect in
nutrient-deprived, hypoxic conditions.
January 12, 2024 at 12:50 PM
One of the key hallmarks recognized 100 years ago, is cancer cells’ remarkable tendency to reprogram their metabolic capability. Inhibition of oxidative phosphorylation (OXPHOS) leads to elevated glycolytic metabolism.
January 11, 2024 at 12:44 PM
While metabolic therapies generally, and specifically, the Press/Pulse protocol, are not yet part of the Standard of Care, the continued and escalating global interest in incorporating them into disease management strategies can be seen here:

clinicaltrials.gov/study/NCT046...
ClinicalTrials.gov
clinicaltrials.gov
January 10, 2024 at 12:41 PM
Carefully studying the rich record of case studies constitutes an effective means of understanding precisely what is required to extract clinically measurable results from the implementation of metabolic therapies. Following, is one such example:

www.cureus.com/articles/101...
Restricted Ketogenic Diet Therapy for Primary Lung Cancer With Metastasis to the Brain: A Case Repor...
A high-fat and low-carbohydrate diet was administered as a complementary and alternative therapy to a 54-year-old man suffering from non-small-cell lung cancer (NSCLC) with brain metastasis. Thr...
www.cureus.com
January 8, 2024 at 12:40 PM
Lonidamine inhibits glycolysis
through its inhibitory effect on mitochondrial-bound Hexokinase II. The inhibition of HK-II by lonidamine leads to decreased glucose phosphorylation.
January 3, 2024 at 12:26 PM
Notably, the dismal record of the Standard of Care persists, insofar that even presumably compelling new drug development, often times only contributes 2.4 months to median Overall Survivorship, across any number of tumor models.
January 2, 2024 at 12:41 PM
Despite advances in the number and specificity of targeted chemotherapeutics, radiation, surgical techniques, immunotherapy and hormone ablatement therapy, more people die from cancer, year over year, every year.
January 1, 2024 at 3:10 PM
As with glucose, the consumption of glutamine via the TCA cycle produces high-energy electrons that are processed through the electron transport chain for the production of ATP. Thus, glutamine is also a major cancer cell energy and anabolic substrate.
December 29, 2023 at 12:11 PM
Tumor cells exhibit a high rate of glutamine consumption that cannot be explained by the nitrogen demand imposed by nucleotide synthesis or maintenance of amino acid pools. Glutamine facilitates the cell's ability to use glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors.
December 28, 2023 at 11:51 AM
Although impaired respiration can render tumor cells dependent on glycolysis for energy in the presence of oxygen (Warburg effect), it has now been demonstrated that glutamine alone can provide enough energy through substrate level phosphorylation in the TCA cycle to maintain tumor cell viability.
December 27, 2023 at 12:52 PM
Notably, in tumor cells, the initial step of glutamine fermentation is driven by glutaminase, which is mitochondrial. Subsequent steps, are catalyzed by transaminases or glutamate dehydrogenase; isocitrate dehydrogenase; aconitase, as performed by either cytosolic or mitochondrial isoforms.
December 26, 2023 at 12:18 PM
"Although in the tumor every oxygen molecule breathed is just as effective as in muscle- the Meyerhof quotient is equal in the two cases- yet the respiration does not cause the glycolysis to disappear. The respiration of the carcinoma tissue is too small in comparison to its glycolytic power."
December 22, 2023 at 12:51 PM
Over a million FDG-PET studies have unequivocally identified increased glucose uptake as a hallmark of metastatic cancer in humans. These observations, combined with new molecular insights with HIF-1α and c-myc, have rekindled an interest in this important phenotype.
December 21, 2023 at 12:47 PM
Warburg proposed that cancer cells cause an injury
to respiration as they progress from a differentiated cellular state to a proliferative state.
The majority of cancer cells use substrate level fermentation to drive increased flux
through the tricarboxylic acid cycle, which promotes tumor growth.
December 20, 2023 at 12:47 PM
The six classical hallmarks of cancer (i.e., limitless replication, self-provision of proliferative stimuli, insensitivity to antiproliferative signals, disabled apoptosis, sustained angiogenesis, invasiveness/metastatic potential), may directly or indirectly implicate dysregulated mitochondria.
December 19, 2023 at 12:41 PM
Study design and methodology are instrumental in demonstrating the level of confidence one can have in the outcomes of any given scientific inquiry. Crucially, in cancer research, the tumor model used in pre-clinical studies is immensely instructive as regards response to interventions.
December 18, 2023 at 1:08 PM
News reports about cancer frequently discuss aggressive treatment and survival but rarely discuss treatment failure, adverse events, end-of-life care, or death. These portrayals of cancer care in media may give patients an inappropriately optimistic view of cancer treatment, outcomes, and prognosis.
December 15, 2023 at 12:45 PM